Xu, F., He, L., Zhan, X., Chen, J., Xu, H., Huang, X., . . . Chen, Y. (2020). DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications. Aging (Albany NY).
Chicago Stili AlıntıXu, Feng, et al. "DNA Methylation-based Lung Adenocarcinoma Subtypes Can Predict Prognosis, Recurrence, and Immunotherapeutic Implications." Aging (Albany NY) 2020.
MLA AlıntıXu, Feng, et al. "DNA Methylation-based Lung Adenocarcinoma Subtypes Can Predict Prognosis, Recurrence, and Immunotherapeutic Implications." Aging (Albany NY) 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..